Publications by authors named "Birgit Wackwitz"

Claim this Profile
F
FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients.
Peter A Fasching, Sebastian M Jud, Maik Hauschild, Sherko Kümmel, Martin Schütte, Birgit Wackwitz

BMC Cancer· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial.
Malgorzata Banys, Erich-Franz Solomayer, Gerhard Gebauer, Wolfgang Janni, Natalia Krawczyk, Birgit Wackwitz

BMC Cancer· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GacA-controlled activation of promoters for small RNA genes in Pseudomonas fluorescens.
Bérénice Humair, Birgit Wackwitz, Dieter Haas

Appl Environ Microbiol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant letrozole in postmenopausal estrogen and/or progesterone receptor positive breast cancer: a phase IIb/III trial to investigate optimal duration of preoperative endocrine therapy.
Ute E Krainick-Strobel, Werner Lichtenegger, Diethelm Wallwiener, Augustinus H Tulusan, Fritz Jänicke, Birgit Wackwitz

BMC Cancer· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of a combined treatment with mTOR inhibitor RAD001 and tamoxifen in vitro on growth and apoptosis of human cancer cells.
Oliver Treeck, Birgit Wackwitz, Ulrike Haus, Olaf Ortmann

Gynecol Oncol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis